ELISA F29 -A therapeutic efficacy biomarker in Chagas disease: Evaluation in pediatric patients treated with nifurtimox and followed for 4 years post-treatment. by Rocio Rivero, Mónica Inés Esteva, Erya Huang, Leylen Colmegna, Jaime Altcheh, Ulrike Grossmann, Andrés Mariano Ruiz, CHICO and CHICO SECURE Study Groups

Connect to this object online.

Target product profile for a test for the early assessment of treatment efficacy in Chagas disease patients: An expert consensus. by Julio Alonso-Padilla, Marcelo Abril, Belkisyolé Alarcón de Noya, Igor C Almeida, Andrea Angheben, Tania Araujo Jorge, Eric Chatelain, Monica Esteva, Joaquim Gascón, Mario J Grijalva, Felipe Guhl, Alejandro Marcel Hasslocher-Moreno, Manuel Carlos López, Alejandro Luquetti, Oscar Noya, María Jesús Pinazo, Janine M Ramsey, Isabela Ribeiro, Andres Mariano Ruiz, Alejandro G Schijman, Sergio Sosa-Estani, M Carmen Thomas, Faustino Torrico, Maan Zrein, Albert Picado

Connect to this object online.

A guide for the generation of repositories of clinical samples for research on Chagas disease. by Nieves Martínez-Peinado, Juan Carlos Gabaldón-Figueira, Roberto Rodrigues Ferreira, María Carmen Thomas, Manuel Carlos López, Tania Cremonini Araújo-Jorge, Belkisyolé Alarcón de Noya, Soledad Berón, Janine Ramsey, Irene Losada Galván, Alejandro Gabriel Schijman, Adriana González Martínez, Andrés Mariano Ruiz, Gimena Rojas, Roberto Magalhães Saraiva, Oscar Noya-González, Andrea Gómez, Rosa A Maldonado, Jimmy Pinto, Faustino Torrico, Ivan Scandale, Fernán Agüero, María-Jesús Pinazo, Joaquim Gascón, Alejandro Marcel Hasslocher-Moreno, Julio Alonso-Padilla, NHEPACHA Network (New Tools for the Diagnosis and Evaluation of Chagas Disease)

Connect to this object online.